BillionToOne, Inc. is disrupting molecular diagnostics, leveraging proprietary smNGS technology for rapid growth and a $5.2B market cap. I rate BLLN stock as Buy. - BillionToOne, Inc. is disrupting molecular diagnostics, leveraging proprietary smNGS technology for rapid growth and a $5.2B market cap.
LONDON, Oct. 15, 2026 (GLOBE NEWSWIRE) -- DaltonTx, the decision engine for drug discovery, today announces that it has been awarded a grant by the Gates Foundation to advance tuberculosis (TB) drug discovery programmes using its AI-enabled platform, Dalton. The award marks a…
Founded by leaders from OpenAI, Terremoto Biosciences, Meta, Devoted Health, and the White House, Warp is using AI and robotics to help biotech and pharma discover new medicines faster in the U.S. The company is backed by Lightspeed, IVP, Mayfield, Lux,…
AI drug discovery is often described with the image of AI coming up with new drug candidates, but its scope of application goes beyond just molecular design. However, 'companies have partnered,' 'a promising candidate has been found,' and 'efficacy has…
A team of Creighton University researchers in Omaha has received a $2.9 million federal grant for a glaucoma research project. The $2.9 million award comes from the National Institutes of Health, according to Kearney Hub. The funding supports Creighton researchers Gopal Jadhav,…
Dec 14, 2022, 07:00 ET AOC 1001 delivered siRNA to skeletal muscle and produced meaningful DMPK reduction in 100% of participants with a 45% mean reduction in DMPK after a single dose of 1 mg/kg or two doses of 2 mg/kg AOC 1001 produced splicing improvement of…
From taladegib to admilparant and inhaled treprostinil, here are the key 2026 advances in idiopathic pulmonary fibrosis care. Researchers and pharmaceutical companies made major strides in idiopathic pulmonary fibrosis (IPF) care this year with a host of investigational clinical trials, new…
Novavax (NVAX) has earned a $125 million milestone payment related to Sanofi's (SNY) initiation of a phase 3 influenza-COVID-19 combination vaccine trial in Europe using Novavax's Nuvaxovid COVID-19... Oops, something went wrong U.S. markets close in 2h 49m Novavax Earns $125 Million Milestone Payment From Sanofi's…
J.P. Morgan analyst Daniel Kerven maintained a Buy rating on RELX plc today and set a price target of £50.70. According to TipRanks, Kerven is ranked #1457 out of 12466 analysts. In addition to J.P. Morgan, RELX plc also received a Buy from…
An experimental drug that Genmab gained in an $8 billion buyout succeeded in a late-stage trial in a form of head and neck cancer, sending shares of the Danish drugmaker soaring to an all-time high. At an early analysis, a combination…
The companies that turn biology into products: big biotechs, pharma's biotech arms, genetic-medicine, platform, tools and diagnostics companies.
An article joins this feed when it matches these terms. Each one is also a search of its own.